To qualify, a person has to have a body mass index of 35 or higher, or 30 and higher if they have a condition such as heart failure, uncontrolled high blood pressure, or kidney failure, the Post said
In terms of prescription focus, semaglutide is primarily prescribed as a treatment for obesity, while liraglutide is prescribed for both obesity and diabetes care
Some sleep specialists are already prescribing GLP-1s to sleep apnea patients with obesity
Ive been self -injecting for 9 years , and Ive never used an out of date ampoule
Mean weight reductions were: 15 mg dose: 20.9 percent 10 mg dose: 19.5 percent 5 mg dose: 15.0 percent Placebo: 3.1 percent At the highest dose, 57 percent of participants lost at least 20 percent of their body weight, and 36 percent lost at least 25 percent [2]